Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 141 articles:
HTML format

Single Articles

    January 2024
  1. ISHIDA N, Takahashi K, Asai Y, Miyazu T, et al
    Albumin change predicts failure in ulcerative colitis treated with adalimumab.
    PLoS One. 2024;19:e0295681.
    PubMed     Abstract available

  2. QIAN Z, Zhang M, Lu T, Yu J, et al
    Propolis alleviates ulcerative colitis injury by inhibiting the protein kinase C - transient receptor potential cation channel subfamily V member 1 - calcitonin gene-related peptide/substance P (PKC-TRPV1-CGRP/SP) signaling axis.
    PLoS One. 2024;19:e0294169.
    PubMed     Abstract available

  3. SCHNITZLER F, Tillack-Schreiber C, Szokodi D, Braun I, et al
    Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center.
    PLoS One. 2024;19:e0290887.
    PubMed     Abstract available

  4. KATHER S, Kacza J, Pfannkuche H, Bottcher D, et al
    Expression of the cobalamin transporters cubam and MRP1 in the canine ileum-Upregulation in chronic inflammatory enteropathy.
    PLoS One. 2024;19:e0296024.
    PubMed     Abstract available

  5. LLUANSI A, Lliros M, Carreras-Torres R, Bahi A, et al
    Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.
    PLoS One. 2024;19:e0297836.
    PubMed     Abstract available

  6. JAMES JP, Riis LB, Sokilde R, Malham M, et al
    Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
    PLoS One. 2024;19:e0297353.
    PubMed     Abstract available

  7. FU C, Wang Q, Chen Y, Zhang Y, et al
    Exploring the causal relationship between airborne particulate matter and ulcerative colitis: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0300066.
    PubMed     Abstract available

  8. RIDSDALE K, Khurana K, Taslim AT, Robinson JK, et al
    Quality improvement exercises in Inflammatory Bowel Disease (IBD) services: A scoping review.
    PLoS One. 2024;19:e0298374.
    PubMed     Abstract available

  9. WANG Z, Nie J, Song X, Denson LA, et al
    A comparison of Bayesian and frequentist approaches to incorporating clinical and biological information for the prediction of response to standardized pediatric colitis therapy.
    PLoS One. 2024;19:e0295814.
    PubMed     Abstract available

  10. CHEN K, Zhang S, Cui G, Zhang X, et al
    Establishment of a hybrid model of atherosclerosis and acute colitis in ApoE-/- mice.
    PLoS One. 2024;19:e0289820.
    PubMed     Abstract available

  11. SALDOVA R, Thomsson KA, Wilkinson H, Chatterjee M, et al
    Characterization of intestinal O-glycome in reactive oxygen species deficiency.
    PLoS One. 2024;19:e0297292.
    PubMed     Abstract available

  12. OCAMPO YC, Castro JP, Pajaro IB, Caro D, et al
    Protective effect of sucrose esters from cape gooseberry (Physalis peruviana L.) in TNBS-induced colitis.
    PLoS One. 2024;19:e0299687.
    PubMed     Abstract available

  13. TORRES-HUERTA A, Ruley-Haase K, Reed T, Boger-May A, et al
    Retinoid orphan receptor gamma t (rorgammat) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis.
    PLoS One. 2024;19:e0300892.
    PubMed     Abstract available

  14. SINCLAIR J, Brooks-Warburton J, Bottoms L
    Perceptions, behaviours and barriers towards exercise practices in inflammatory bowel disease.
    PLoS One. 2024;19:e0299228.
    PubMed     Abstract available

  15. QUENEHERVE L, Trang-Poisson C, Fantou A, Flamant M, et al
    Confocal laser endomicroscopy as predictive biomarker of clinical and endoscopic efficacy of vedolizumab in ulcerative colitis: The DETECT study.
    PLoS One. 2024;19:e0298313.
    PubMed     Abstract available

  16. HU J, Huang Y, Jia R, Wang X, et al
    Absolute monocyte counts could predict disease activity and secondary loss of response of patients with Crohn's disease treated with anti-TNF-alpha drug.
    PLoS One. 2024;19:e0301797.
    PubMed     Abstract available

  17. FU W, Zhu B, Chen J, Jin X, et al
    Risk relationship between inflammatory bowel disease and urolithiasis: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0301545.
    PubMed     Abstract available

  18. WU H, Jiang F, Yuan W, Zhao Y, et al
    Rauwolfia polysaccharide can inhibit the progress of ulcerative colitis through NOS2-mediated JAK2/STAT3 pathway.
    PLoS One. 2024;19:e0301660.
    PubMed     Abstract available

  19. XU F, Carlson SA, Greenlund KJ
    Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
    PLoS One. 2024;19:e0299890.
    PubMed     Abstract available

  20. ALAHDAL H, Almuneef G, Alkhulaifi MM, Aldibasi O, et al
    Gut microbiota composition in patients with Crohn's disease in Saudi Arabia.
    PLoS One. 2024;19:e0299749.
    PubMed     Abstract available

  21. KODAMA M, Okano S, Nojri S, Abe K, et al
    Longitudinal and regional association between dietary factors and prevalence of Crohn's disease in Japan.
    PLoS One. 2024;19:e0300580.
    PubMed     Abstract available

  22. WANG X, Li T, Chen Q
    Causal relationship between ulcerative colitis and male infertility: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0303827.
    PubMed     Abstract available

  23. RANA T, Korolkova OY, Rachakonda G, Williams AD, et al
    Correction: Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.
    PLoS One. 2024;19:e0304732.
    PubMed     Abstract available

  24. Sources of diagnostic delay for people with Crohn's disease and ulcerative colitis: Qualitative research study.
    PLoS One. 2024;19:e0301672.
    PubMed     Abstract available

  25. LI L, Zhang M, Gu M, Li J, et al
    The causal relationship between autoimmune diseases and age-related macular degeneration: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0303170.
    PubMed     Abstract available

  26. CHI G, Pei J, Li X
    Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
    PLoS One. 2024;19:e0305220.
    PubMed     Abstract available

  27. ZHANG K, Nakaoka S
    An energy landscape approach reveals the potential key bacteria contributing to the development of inflammatory bowel disease.
    PLoS One. 2024;19:e0302151.
    PubMed     Abstract available

  28. WANG N, Li Z, Cao L, Cui Z, et al
    Trilobatin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice via the NF-kappaB pathway and alterations in gut microbiota.
    PLoS One. 2024;19:e0305926.
    PubMed     Abstract available

  29. KHANMOHAMMADI S, Sheidaei A, Alatab S, Tabatabaei-Malazy O, et al
    Sex and age differences in inflammatory bowel disease patients; a nationwide study based on Iranian Registry of Crohn's and Colitis (IRCC).
    PLoS One. 2024;19:e0304792.
    PubMed     Abstract available

  30. JONES K, Kimble R, Baker K, Tew GA, et al
    Correction: Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease (IBD): A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307509.
    PubMed     Abstract available

    January 2023
  31. KURIMOTO N, Nishida Y, Hosomi S, Itani S, et al
    Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing.
    PLoS One. 2023;18:e0280252.
    PubMed     Abstract available

  32. Expression of Concern: Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.
    PLoS One. 2023;18:e0280122.

  33. LEE C, Kim S, Kim B, Holzapfel WH, et al
    Disturbance of lipid metabolism in germ-free mice transplanted with gut microbiota of DSS-induced colitis mice.
    PLoS One. 2023;18:e0280850.
    PubMed     Abstract available

  34. NISHIO M, Kunisaki R, Shibata W, Ajioka Y, et al
    Serrated polyps in patients with ulcerative colitis: Unique clinicopathological and biological characteristics.
    PLoS One. 2023;18:e0282204.
    PubMed     Abstract available

  35. RUDRAPATNA VA, Cheng YW, Feuille C, Mosenia A, et al
    Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study.
    PLoS One. 2023;18:e0282267.
    PubMed     Abstract available

  36. ZONG W, Patel A, Chang V, Mitchel EB, et al
    Clinical and lifestyle patterns in Asian children with inflammatory bowel disease in the U.S.
    PLoS One. 2023;18:e0281949.
    PubMed     Abstract available

  37. SCHORLING E, Lick S, Steinberg P, Bruggemann DA, et al
    Health care utilizations and costs of Campylobacter enteritis in Germany: A claims data analysis.
    PLoS One. 2023;18:e0283865.
    PubMed     Abstract available

  38. TANI M, Shinzaki S, Asakura A, Tashiro T, et al
    Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease.
    PLoS One. 2023;18:e0283880.
    PubMed     Abstract available

  39. HASAN N, Yang H
    Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models.
    PLoS One. 2023;18:e0285613.
    PubMed     Abstract available

  40. ICHIMIYA T, Kazama T, Ishigami K, Yokoyama Y, et al
    Application of plasma alternative to serum for measuring leucine-rich alpha2-glycoprotein as a biomarker of inflammatory bowel disease.
    PLoS One. 2023;18:e0286415.
    PubMed     Abstract available

  41. DONG F, Kern I, Weidner J, Kugler K, et al
    Clinical course of new-onset Crohn's disease in children and adolescents in dependency of age, initial location, initial severity level and therapy over the period 2000-2014 based on the Saxon Pediatric IBD-Registry in Germany.
    PLoS One. 2023;18:e0287860.
    PubMed     Abstract available

  42. NAGAHORI M, Imai T, Nakashoji M, Tairaka A, et al
    A web-based survey on self-management for patients with inflammatory bowel disease in Japan.
    PLoS One. 2023;18:e0287618.
    PubMed     Abstract available

  43. HATAMNEJAD MR, Shirvani M, Pourhoseingholi MA, Balaii H, et al
    Translation and cross-cultural adaptation of the Persian version of inflammatory bowel disease-fatigue (IBD-F) self-assessment questionnaire.
    PLoS One. 2023;18:e0288592.
    PubMed     Abstract available

  44. PATRA R, Dey AK, Mukherjee S
    Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma.
    PLoS One. 2023;18:e0289064.
    PubMed     Abstract available

  45. LIN A, Tan Y, Chen J, Liu X, et al
    Development of ankylosing spondylitis in patients with ulcerative colitis: A systematic meta-analysis.
    PLoS One. 2023;18:e0289021.
    PubMed     Abstract available

  46. OTAKE-KASAMOTO Y, Shinzaki S, Hiyama S, Tashiro T, et al
    Carbon dioxide insufflation reduces the relapse of ulcerative colitis after colonoscopy: A randomized controlled trial.
    PLoS One. 2023;18:e0290329.
    PubMed     Abstract available

  47. LIU Y, Zhang YZ, Imoto S
    Microbial Gene Ontology informed deep neural network for microbe functionality discovery in human diseases.
    PLoS One. 2023;18:e0290307.
    PubMed     Abstract available

  48. MEUNIER M, Spillmann A, Rousseaux C, Schwamborn K, et al
    An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease.
    PLoS One. 2023;18:e0283489.
    PubMed     Abstract available

  49. KAZAMA T, Ando K, Ueno N, Fujiya M, et al
    Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study.
    PLoS One. 2023;18:e0288393.
    PubMed     Abstract available

  50. SAKOWITZ S, Bakhtiyar SS, Mallick S, Khoraminejad B, et al
    Decreasing rates of colectomy for benign neoplasms: A nationwide analysis.
    PLoS One. 2023;18:e0293389.
    PubMed     Abstract available

  51. CHAE K, Seo YS, Yu YM, Chang MJ, et al
    An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis.
    PLoS One. 2023;18:e0293655.
    PubMed     Abstract available

  52. OTT A, Tutdibi E, Goedicke-Fritz S, Schope J, et al
    Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease.
    PLoS One. 2023;18:e0288147.
    PubMed     Abstract available

  53. KONECNY AJ, Shows DM, Lord JD
    Colonic mucosal associated invariant T cells in Crohn's disease have a diverse and non-public T cell receptor beta chain repertoire.
    PLoS One. 2023;18:e0285918.
    PubMed     Abstract available

  54. WASSERBAUER M, Mala S, Stechova K, Hlava S, et al
    Dysfunction of peripheral somatic and autonomic nervous system in patients with severe forms of Crohn's disease on biological therapy with TNFalpha inhibitors-A single center study.
    PLoS One. 2023;18:e0294441.
    PubMed     Abstract available

  55. BAR O, Sudhof LS, Yockey LJ, Bergerat A, et al
    Comparison of vaginal microbiota between women with inflammatory bowel disease and healthy controls.
    PLoS One. 2023;18:e0284709.
    PubMed     Abstract available

  56. YIN T, Ye R, Wang Q, Wang L, et al
    Difficulties in eating out of home while diagnosed with inflammatory bowel disease: A qualitative interview study from China.
    PLoS One. 2023;18:e0288908.
    PubMed     Abstract available

  57. TATARU C, Livni M, Marean-Reardon C, Franco MC, et al
    Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology.
    PLoS One. 2023;18:e0289314.
    PubMed     Abstract available

  58. SUN W, Li E, Mao X, Zhang Y, et al
    The oligosaccharides of Xiasangju alleviates dextran sulfate sodium-induced colitis in mice by inhibiting inflammation.
    PLoS One. 2023;18:e0295324.
    PubMed     Abstract available

  59. PACHECO M, Sa P, Santos G, Boa-Sorte N, et al
    Impact of an intervention program on drug adherence in patients with ulcerative colitis: Randomized clinical trial.
    PLoS One. 2023;18:e0295832.
    PubMed     Abstract available

  60. SARDARI A, Usefi H
    Machine learning-based meta-analysis of colorectal cancer and inflammatory bowel disease.
    PLoS One. 2023;18:e0290192.
    PubMed     Abstract available

  61. LEE YC, Kim TJ, Kim JH, Lee E, et al
    Short-term effects of ambient temperature on acute exacerbation of inflammatory bowel disease: A nationwide case-crossover study with external validation.
    PLoS One. 2023;18:e0291713.
    PubMed     Abstract available

    January 2022
  62. PARK J, Yoon H, Shin CM, Park YS, et al
    Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study.
    PLoS One. 2022;17:e0262571.
    PubMed     Abstract available

  63. BAKER KA, Miller TD, Marino FE, Hartmann TE, et al
    The exercise-induced inflammatory response in inflammatory bowel disease: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0262534.
    PubMed     Abstract available

  64. LAI HC, Chou JW, Wu YH, Huang PJ, et al
    ABO blood type and clinical characteristics of patients with ulcerative colitis: A hospital-based study in central Taiwan.
    PLoS One. 2022;17:e0260018.
    PubMed     Abstract available

  65. XU F, Wheaton AG, Liu Y, Greenlund KJ, et al
    Major ambulatory surgery among US adults with inflammatory bowel disease, 2017.
    PLoS One. 2022;17:e0264372.
    PubMed     Abstract available

  66. GARDINER LJ, Carrieri AP, Bingham K, Macluskie G, et al
    Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease.
    PLoS One. 2022;17:e0263248.
    PubMed     Abstract available

  67. TONG G, Qian H, Li D, Li J, et al
    Establishment and evaluation of a specific antibiotic-induced inflammatory bowel disease model in rats.
    PLoS One. 2022;17:e0264194.
    PubMed     Abstract available

  68. SAETERSTAD S, Ostvik AE, Royset ES, Bakke I, et al
    Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn's disease.
    PLoS One. 2022;17:e0265189.
    PubMed     Abstract available

  69. YAO J, Fekadu G, Jiang X, You JHS, et al
    Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic-A cost-effectiveness analysis.
    PLoS One. 2022;17:e0266464.
    PubMed     Abstract available

  70. LEE SH, Veeriah V, Levine F
    A potent HNF4alpha agonist reveals that HNF4alpha controls genes important in inflammatory bowel disease and Paneth cells.
    PLoS One. 2022;17:e0266066.
    PubMed     Abstract available

  71. NGUYEN TB, Do DN, Nguyen TTP, Nguyen TL, et al
    Immune-related biomarkers shared by inflammatory bowel disease and liver cancer.
    PLoS One. 2022;17:e0267358.
    PubMed     Abstract available

  72. WAKAI M, Hayashi R, Ueno Y, Onishi K, et al
    Promoting mechanism of serum amyloid a family expression in mouse intestinal epithelial cells.
    PLoS One. 2022;17:e0264836.
    PubMed     Abstract available

  73. SHEU NW, Huang SH, Wu DC, Kao JY, et al
    Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
    PLoS One. 2022;17:e0265323.
    PubMed     Abstract available

  74. WEDENOJA S, Saarikivi A, Malkonen J, Leskinen S, et al
    Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.
    PLoS One. 2022;17:e0269561.
    PubMed     Abstract available

  75. HIGUCHI N, Hiraga H, Sasaki Y, Hiraga N, et al
    Automated evaluation of colon capsule endoscopic severity of ulcerative colitis using ResNet50.
    PLoS One. 2022;17:e0269728.
    PubMed     Abstract available

  76. WANG J, Kou F, Han X, Shi L, et al
    Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis.
    PLoS One. 2022;17:e0270297.
    PubMed     Abstract available

  77. OZAKA S, Sonoda A, Ariki S, Minata M, et al
    Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    PLoS One. 2022;17:e0269698.
    PubMed     Abstract available

  78. DAS B, Rabalais J, Kozan P, Lu T, et al
    The effect of a fennel seed extract on the STAT signaling and intestinal barrier function.
    PLoS One. 2022;17:e0271045.
    PubMed     Abstract available

  79. HANSEN TM, Nugent Z, Bernstein CN, Samadder NJ, et al
    Characteristics of colorectal cancer and use of colonoscopy before colorectal cancer diagnosis among individuals with inflammatory bowel disease: A population-based study.
    PLoS One. 2022;17:e0272158.
    PubMed     Abstract available

  80. WASSERBAUER M, Hlava S, Drabek J, Stovicek J, et al
    Adalimumab biosimilars in the therapy of Crohn s disease and ulcerative colitis: Prospective multicentric clinical monitoring.
    PLoS One. 2022;17:e0271299.
    PubMed     Abstract available

  81. KANG YH, Tucker SA, Quevedo SF, Inal A, et al
    Metabolic analyses reveal dysregulated NAD+ metabolism and altered mitochondrial state in ulcerative colitis.
    PLoS One. 2022;17:e0273080.
    PubMed     Abstract available

  82. WASSERBAUER M, Hlava S, Trojanek M, Stovicek J, et al
    Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.
    PLoS One. 2022;17:e0273612.
    PubMed     Abstract available

  83. BAMBO GM, Shiferaw E, Melku M
    A mean platelet volume in inflammatory bowel disease: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0273417.
    PubMed     Abstract available

  84. KERN I, Schoffer O, Richter T, Kiess W, et al
    Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000-2014 -a 15-year evaluation of trends.
    PLoS One. 2022;17:e0274117.
    PubMed     Abstract available

  85. BIANCHI R, Mamadou-Pathe B, von Kanel R, Roth R, et al
    Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patients.
    PLoS One. 2022;17:e0274665.
    PubMed     Abstract available

  86. ELAMIR A, Shaker O, Kamal M, Khalefa A, et al
    Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease.
    PLoS One. 2022;17:e0275267.
    PubMed     Abstract available

  87. COLLIER AJ, Gomez DE, Monteith G, Plattner BL, et al
    Investigating fecal microbial transplant as a novel therapy in dogs with inflammatory bowel disease: A preliminary study.
    PLoS One. 2022;17:e0276295.
    PubMed     Abstract available

  88. DOTTI I, Mayorgas A, Salas A
    Generation of human colon organoids from healthy and inflammatory bowel disease mucosa.
    PLoS One. 2022;17:e0276195.
    PubMed     Abstract available

  89. THOMAS S, Mercogliano G, Prendergast GC
    Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment.
    PLoS One. 2022;17:e0276910.
    PubMed     Abstract available

  90. SAHIN M, Erdogan KE, Tekingunduz E
    Correlation between the tissue ghrelin presence, disease activity and laboratory parameters in ulcerative colitis patients; immunohistochemical study.
    PLoS One. 2022;17:e0276065.
    PubMed     Abstract available

  91. JONES K, Kimble R, Baker K, Tew GA, et al
    Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease (IBD): A systematic review and meta-analysis.
    PLoS One. 2022;17:e0278480.
    PubMed     Abstract available

  92. MOON SJ, Lee YC, Kim TJ, Kim K, et al
    Effects of temperature, weather, seasons, atmosphere, and climate on the exacerbation of inflammatory bowel diseases: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0279277.
    PubMed     Abstract available

  93. COHEN-MEKELBURG S, Van T, Yu X, Costa DK, et al
    Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease care.
    PLoS One. 2022;17:e0279441.
    PubMed     Abstract available

  94. ROB F, Schierova D, Stehlikova Z, Kreisinger J, et al
    Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.
    PLoS One. 2022;17:e0277576.
    PubMed     Abstract available

    January 2021
  95. KERN I, Schoffer O, Kiess W, Henker J, et al
    Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry.
    PLoS One. 2021;16:e0243774.
    PubMed     Abstract available

  96. KONSTANTINIDIS AO, Adamama-Moraitou KK, Pardali D, Dovas CI, et al
    Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score.
    PLoS One. 2021;16:e0245713.
    PubMed     Abstract available

  97. NAFTALI T, Bar-Lev Schleider L, Scklerovsky Benjaminov F, Konikoff FM, et al
    Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.
    PLoS One. 2021;16:e0246871.
    PubMed     Abstract available

  98. REVILLA L, Mayorgas A, Corraliza AM, Masamunt MC, et al
    Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis.
    PLoS One. 2021;16:e0246367.
    PubMed     Abstract available

  99. DING ZH, Xu XP, Wang TR, Liang X, et al
    The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study.
    PLoS One. 2021;16:e0248427.
    PubMed     Abstract available

  100. RANA T, Korolkova OY, Rachakonda G, Williams AD, et al
    Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.
    PLoS One. 2021;16:e0246393.
    PubMed     Abstract available

  101. ARKTEG CB, Wergeland Sorbye S, Buhl Riis L, Dalen SM, et al
    Real-life evaluation of histologic scores for Ulcerative Colitis in remission.
    PLoS One. 2021;16:e0248224.
    PubMed     Abstract available

  102. TAMAN H, Fenton CG, Anderssen E, Florholmen J, et al
    DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis.
    PLoS One. 2021;16:e0248905.
    PubMed     Abstract available

  103. FURUSE M, Hosomi S, Nishida Y, Itani S, et al
    The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients.
    PLoS One. 2021;16:e0250597.
    PubMed     Abstract available

  104. XU F, Park S, Liu Y, Greenlund KJ, et al
    Dietary intake patterns among adults with inflammatory bowel disease in the United States, 2015.
    PLoS One. 2021;16:e0250441.
    PubMed     Abstract available

  105. ISHIDA N, Higuchi T, Miyazu T, Tamura S, et al
    Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease.
    PLoS One. 2021;16:e0250658.
    PubMed     Abstract available

  106. BUSINGYE D, Pollack A, Chidwick K
    Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    PLoS One. 2021;16:e0252458.
    PubMed     Abstract available

  107. TREFZER R, Elpeleg O, Gabrusskaya T, Stepensky P, et al
    Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease.
    PLoS One. 2021;16:e0252428.
    PubMed     Abstract available

  108. YEN HH, Su PY, Huang SP, Wu L, et al
    Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    PLoS One. 2021;16:e0252286.
    PubMed     Abstract available

  109. SMITH SCL, Banbury C, Zardo D, Cannatelli R, et al
    Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease.
    PLoS One. 2021;16:e0252210.
    PubMed     Abstract available

  110. CAPITANO ML, Jaiswal A, Broxmeyer HE, Pride Y, et al
    A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease.
    PLoS One. 2021;16:e0252805.
    PubMed     Abstract available

  111. KATO M, Sugimoto K, Ikeya K, Takano R, et al
    Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.
    PLoS One. 2021;16:e0254548.
    PubMed     Abstract available

  112. ORFEI M, Gasparetto M, Hensel KO, Zellweger F, et al
    Guidance on the interpretation of faecal calprotectin levels in children.
    PLoS One. 2021;16:e0246091.
    PubMed     Abstract available

  113. MADARAME A, Fukuzawa M, Yamauchi Y, Kono S, et al
    Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.
    PLoS One. 2021;16:e0255620.
    PubMed     Abstract available

  114. LEE JM, Jang JH, Ryu JH, Yoo J, et al
    A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    PLoS One. 2021;16:e0255974.
    PubMed     Abstract available

  115. GAN RW, Sun D, Tatro AR, Cohen-Mekelburg S, et al
    Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease.
    PLoS One. 2021;16:e0257520.
    PubMed     Abstract available

  116. ZHANG L, Wu YB, Dai YK, Liu Q, et al
    Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis.
    PLoS One. 2021;16:e0257599.
    PubMed     Abstract available

  117. KARMI N, Bangma A, Spekhorst LM, van Dullemen HM, et al
    Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFalpha therapy in inflammatory bowel disease.
    PLoS One. 2021;16:e0256860.
    PubMed     Abstract available

  118. AL-SADI R, Engers J, Haque M, King S, et al
    Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-kappaB activation.
    PLoS One. 2021;16:e0249544.
    PubMed     Abstract available

  119. CREEMERS RH, Rezazadeh Ardabili A, Jonkers DM, Leers MPG, et al
    Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    PLoS One. 2021;16:e0258271.
    PubMed     Abstract available

  120. TAO F, Xing X, Wu J, Jiang R, et al
    Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.
    PLoS One. 2021;16:e0248482.
    PubMed     Abstract available

  121. MEI Z, Feng Q, Du P, Li B, et al
    Surgical treatment for cryptoglandular and Crohn's perianal fistulas: Protocol of an umbrella review.
    PLoS One. 2021;16:e0251460.
    PubMed     Abstract available

  122. MORAN MM, Wessman P, Rolfson O, Bohl DD, et al
    The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study.
    PLoS One. 2021;16:e0257310.
    PubMed     Abstract available

  123. BIN MASUD S, Jenkins C, Hussey E, Elkin-Frankston S, et al
    Utilizing machine learning with knockoff filtering to extract significant metabolites in Crohn's disease with a publicly available untargeted metabolomics dataset.
    PLoS One. 2021;16:e0255240.
    PubMed     Abstract available

  124. MIYAZAKI C, Katsumasa N, Huang KC, Liu YF, et al
    Evaluation of economic burden with biologic treatments in Crohn's disease patients: A mirror image study using an insurance database in Japan.
    PLoS One. 2021;16:e0254807.
    PubMed     Abstract available

  125. WILSON PA, Santos Franco S, He L, Galwey NW, et al
    Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells.
    PLoS One. 2021;16:e0258316.
    PubMed     Abstract available

  126. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed     Abstract available

  127. PARK HT, Park WB, Kim S, Lim JS, et al
    Revealing immune responses in the Mycobacterium avium subsp. paratuberculosis-infected THP-1 cells using single cell RNA-sequencing.
    PLoS One. 2021;16:e0254194.
    PubMed     Abstract available

  128. WANG J, Bleich RM, Zarmer S, Zhang S, et al
    Long-read sequencing to interrogate strain-level variation among adherent-invasive Escherichia coli isolated from human intestinal tissue.
    PLoS One. 2021;16:e0259141.
    PubMed     Abstract available

  129. MORIKUBO H, Kobayashi T, Fukuda T, Nagahama T, et al
    Development of algorithms for identifying patients with Crohn's disease in the Japanese health insurance claims database.
    PLoS One. 2021;16:e0258537.
    PubMed     Abstract available

  130. IRAK K, Bayram M, Cifci S, Sener G, et al
    Serum levels of NLRC4 and MCP-2/CCL8 in patients with active Crohn's disease.
    PLoS One. 2021;16:e0260034.
    PubMed     Abstract available

  131. KHAN IA, Nayak B, Markandey M, Bajaj A, et al
    Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis.
    PLoS One. 2021;16:e0256098.
    PubMed     Abstract available

  132. ZHANG J, Wang XJ, Wu LJ, Yang L, et al
    Herb-partitioned moxibustion alleviates colonic inflammation in Crohn's disease rats by inhibiting hyperactivation of the NLRP3 inflammasome via regulation of the P2X7R-Pannexin-1 signaling pathway.
    PLoS One. 2021;16:e0252334.
    PubMed     Abstract available

  133. SCHINEIS C, Ullrich A, Lehmann KS, Holmer C, et al
    Microscopic inflammation in ileocecal specimen does not correspond to a higher anastomotic leakage rate after ileocecal resection in Crohn's disease.
    PLoS One. 2021;16:e0247796.
    PubMed     Abstract available

    January 2020
  134. CAI B, Zhou MH, Huang HL, Zhou AC, et al
    Protective effects of citrulline supplementation in ulcerative colitis rats.
    PLoS One. 2020;15:e0240883.
    PubMed     Abstract available

  135. ALLAIS L, Verschuere S, Maes T, De Smet R, et al
    Translational research into the effects of cigarette smoke on inflammatory mediators and epithelial TRPV1 in Crohn's disease.
    PLoS One. 2020;15:e0236657.
    PubMed     Abstract available

  136. NISHIDA Y, Hosomi S, Yamagami H, Fujimoto K, et al
    Novel prognostic biomarkers of pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: Neutrophil-to-lymphocyte ratio.
    PLoS One. 2020;15:e0241322.
    PubMed     Abstract available

  137. UCHIYAMA K, Takami S, Suzuki H, Umeki K, et al
    Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial.
    PLoS One. 2020;15:e0241337.
    PubMed     Abstract available

  138. HOFFMANN P, Behnisch R, Gsenger J, Schnitzler P, et al
    Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases.
    PLoS One. 2020;15:e0239825.
    PubMed     Abstract available

  139. LIMSRIVILAI J, Lee CK, Prueksapanich P, Harinwan K, et al
    Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.
    PLoS One. 2020;15:e0242879.
    PubMed     Abstract available

  140. DOMENIS R, Marino M, Cifu A, Scardino G, et al
    Circulating exosomes express alpha4beta7 integrin and compete with CD4+ T cells for the binding to Vedolizumab.
    PLoS One. 2020;15:e0242342.
    PubMed     Abstract available

  141. LI LN, Liu Y, Zhang HC, Wu T, et al
    Helicobacter pylori infection reduces TAMs infiltration in a mouse model of AOM/DSS induced colitis-associated cancer.
    PLoS One. 2020;15:e0241840.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.